Authors
Latest:
Case 3: Treating nAMD in the Presence of Geographic AtrophyRetina experts deliberate on the role of fluorescein angiography in AMD and discuss initiation of anticomplement therapy for geographic atrophy in conjunction with anti-VEGF therapy for neovascular AMD.
Latest:
Cryopreserved amniotic membrane an option treatment of mechanical dry eyeReservoir restoration can re establish the normal anatomy and function of the conjunctiva.
Latest:
Study examines efficiency of physiotherapy in treating, preventing uncomplicated acquired myopiaResearch explores innovative physiotherapeutic approaches to managing myopia progression, showing promising results in slowing its advancement over two years.
Latest:
New molecule for allergic conjunctivitis makes debutFirst new therapy in nearly a decade offers another option for physicians, patients
Latest:
Good nutrition optimizes ocular surface in premium cataract patientsImprovements gained prior to surgery can result in positive outcomes.
Latest:
Froin syndrome: Eyes are the window to the spinePapilledema with back pain suggests spine lesion.
Latest:
Blog: In honor of those who lift usIt’s been a minute, as the Baltimorean’s say, but I still remember my first day of residency. I knew next to nothing about ophthalmology but showed up smiling and eager to learn. I felt incredibly fortunate to be training at such a prestigious institution. I was awed by the distinguished faculty, and my co-residents couldn’t be any more impressive. In short, I wasn’t sure I belonged.
Latest:
More to keratoconus than meets the cornea: Be sure to flip the lidsEqually important is that any symptoms of ocular allergies should be addressed to reduce the frequency of eye rubbing.
Latest:
Envision Summit 2025: Deep learning models of neovascular AMDAt the Envision Summit 2025 in San Juan, Puerto Rico, retina program chairs Geeta Lalwani, MD, and Majda Hadziahmetovic, MD, discussed Hadziahmetovic's presentation on deep learning models of neovascular AMD as well as their time at the conference.
Latest:
Case 3: Treating nAMD in the Presence of Geographic AtrophyRetina experts deliberate on the role of fluorescein angiography in AMD and discuss initiation of anticomplement therapy for geographic atrophy in conjunction with anti-VEGF therapy for neovascular AMD.
Latest:
ACHIEVING IMPROVED OUTCOMES THROUGH PARTNERSHIPS BETWEEN OPTOMETRISTS AND RETINA SPECIALISTSConsiderations in the treatment of diabetic retinopathy and diabetic macular edema.
Latest:
Tackling the challenge of noninfectious uveitisChronic cases can be difficult for retinal specialists, but treatment is satisfying.
Latest:
Navigating the COVID-19 pandemic with ophthalmic patients in the hospital settingNew operating procedures ensure eye clinics can operate safely amid virus.
Latest:
ARVO 2025: Sex-specific biomarkers for Parkinson's disease in retinal microvascular imagingAt the ARVO 2025 meeting in Salt Lake City, Utah, Cameron Cummings presented a poster on how retinal microvascular imaging metrics may show sex-specific biomarkers for Parkinson's disease.
Latest:
The Residency Report: Study provides new insights into USH2A target end pointsResearchers evaluate key measures for tracking disease progression in Usher syndrome type 2–related retinal degeneration
Latest:
BLOG: The PTVT Trial and Clinical ApplicationsJoseph F. Panarelli MD, Steven J. Gedde, MD, and Vikram Paranjpe MD, MPH discuss the Primary Tube Versus Trabeculectomy (PTVT) study.
Latest:
The Impressions and Takeaways from Patient Case No. 2An expert underscores the importance of a comprehensive dry eye examination and offers insights on distinguishing it from neurotrophic keratitis.
Latest:
The path forward for oculomics and AIThe AI-READI project aims to establish fair, equitable, and ethical access to big data, enhancing artificial intelligence’s ability to diagnose systemic diseases and drive progress in ophthalmology research.
Latest:
New presbyopia-correcting IOL provides spectacle independenceLens combines diffractive multifocal and extended depth-of-focus properties.
Latest:
Assessing the quality of real-world evidence in retinal diseasesReal-world evidence is growing in importance as a source of information that can help support clinical decision-making when evaluated properly.
Latest:
ARVO 2025: Analysis of birdshot retinochoroidopathy.At ARVO 2025, in Salt Lake City, Utah, C Michael Samson, MD, MBA, gave insight into his data on immune cell profiling in birdshot retinochoroidopathy using single-cell RNA sequencing.
Latest:
The ABCs of canaloplastyNot only is canaloplasty designed to treat the entire conventional outflow pathway, facilitating flow through the trabecular meshwork, Schlemm canal, and collector channels, but it does so without a stent and without removing tissue.
Latest:
Envision Summit 2025: How to use the new G2211 codeAt the Envision Summit 2025 in San Juan, Puerto Rico, Lana Rifkin, MD, gave clinicians advice on how, and when it may be most appropriate to use the new G2211 code.
Latest:
Q&A: Priya S. Vakharia, MD, shares insight into the Phase 2 ARCHER trial for GAVakharia insights from the ARCHER trial on geographic atrophy treatment for dry AMD, highlighting promising results and future directions in ophthalmology.
